Bacteria that have SARS-CoV-2 virus proteins on their surface are the basis of a potential oral vaccine that is being studied by researchers from the IGC and ITQB NOVA, in a joint effort to find more tools to stop the current pandemic. The second phase of the study will assess the quality of the immune system’s response and the strength of protection against infection conferred after taking this vaccine.

Check the latest news in the press about this study (in Portuguese):

in RTP

in Público

in Observador

in Jornal de Notícias

in Diário de Notícias

in Visão

in TVI

in TSF 

in Renascença